Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-World Effectiveness and Safety of Dabigatran in Geriatric Patients with Atrial Fibrillation
TCTR20221222001Unknown
- Sponsor
- Faculty of Pharmacy, Silpakorn University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of dabigatran in Atrial fibrillation (AFib), sponsored by Faculty of Pharmacy, Silpakorn University. Primary endpoints: Effectiveness outcomes and Safety outcomes. Status: unknown.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20221222001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221222001.